Leon Chen - Profile and Investment Details

Investor Profile

Leon Chen is a Venture Capital, Private Equity Firm based in Palo Alto, California, United States with a diverse investment portfolio that includes companies such as Exonics Therapeutics, Remix Therapeutics, NGM Biopharmaceuticals, Constellation Pharmaceuticals, Peloton Therapeutics, Carmot Therapeutics, KallyopePTC Therapeutics, Seragon Pharmaceuticals, Immune Design, Sagimet Biosciences, Cyterix Pharmaceuticals, Hexagon Bio, Circle Pharma, Tenaya Therapeutics, Igenica, ORIC Pharmaceuticals, Casma Therapeutics, Surrozen, Accent Therapeutics, ProNeurotech, Escient Pharmaceuticals, A2 Biotherapeutics, Effector Therapeutics, Gritstone Oncology, Revolution Medicines, Neurona Therapeutics, Rapt Therapeutics, Arcus Biosciences, Plexium, Synthekine, Nurix Therapeutics, Ribon Therapeutics, Flexus Biosciences, Aragon Pharmaceuticals, . Over time, Leon Chen has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Leon Chen is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Regenerative Medicine, Drug Discovery, Wellness, Women Founded, Life Science, Engineering, Portfolio Management, Education, Finance, Biotechnology, Medical, B2B, Therapeutics, Pharmaceuticals may find it worthwhile to explore potential connections with Leon Chen, as their portfolio suggests a familiarity and interest in this area.

Understanding Leon Chen’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.